Conflux’s CFX: China’s New Crypto Dream or Dystopia?

But here’s the catch: none of this is happening on-chain. It’s like a party where everyone’s at the door, but no one’s inside. 🚪

But here’s the catch: none of this is happening on-chain. It’s like a party where everyone’s at the door, but no one’s inside. 🚪
Our stalwart tokens, Bitcoin (BTC) and Ethereum (ETH), have held their ground with the tenacity of a bear in hibernation, undeterred by the tumultuous waves of global macroeconomic pressures and the internal squabbles of volatility. While the short-term fluctuations continue to dance about like a lively waltz, the broader market exhibits signs of stabilization, buoyed by the accumulation of whales and the shifting tides of liquidity.

Dividend-paying stocks offer a stream of income, a trickle of resources against the potential flood. It’s not *getting* richer, precisely. It’s more…avoiding poorer at quite the same rate.1 And let’s be clear, it requires a modicum of faith. Faith that the company in question can actually *afford* to send you cheques, or these days, deposit a few coppers into your digital pouch. Here are three establishments warranting a closer look, as of this particular rotation of the celestial spheres.

Crypto treasuries, those modern-day alchemists, have turned Bitcoin into a corporate trophy. Strategy (NASDAQ: MSTR), once a name that evoked spreadsheets, now hoards 3% of Bitcoin’s supply. But the real spectacle lies in the copycats—pork processors turned Dogecoin barons, and dot-com survivors pivoting to NFTs with the urgency of a man fleeing a sinking ship. This is not fiscal prudence; it is the financial equivalent of a stampede of ostriches, heads buried in sand, hoping the ground won’t crack beneath them.
Lo! His words come hot on the heels of a revelation from the learned gentlemen of Microsoft, who have uncovered a list most dire of forty roles most susceptible to the iron grip of automation—roles that flourish within the realm of cryptocurrency and beyond. Yet Monsieur Sacks, with a twinkle in his eye, denieth such alarms, asserting that the narrative of job destruction is but a potion brewed with exaggeration and folly. 🍵

And get this: Exxon’s not just resting on its laurels. No, no. They’re positioning themselves to keep delivering these leading results, which makes them a pretty compelling oil stock to buy and hold for the long term. But let’s be honest, are we really surprised? This is Exxon we’re talking about. They’re like the guy who always wins at poker, even when you’re convinced you’ve got the better hand.

Wall Street. A colony of hyperactive squirrels. Short attention spans, easily distracted by the next shiny thing. This is exquisitely good news for those of us capable of remembering what day it is, let alone thinking in *decades*. General Mills, the silent overlord of breakfast cereals and processed everything, is experiencing a mild…malaise. Sales down 2% last quarter. Cue the panic. The vultures circling. Which, naturally, pumps the dividend yield to a screaming 4.8%. SWEET.

At $1.9 trillion, Meta’s ascent appears inevitable to the optimists. Its stock, they say, needs but a 53% rise—a mere stumble in Wall Street’s casino. The prophets chant of AI-driven ads converting clicks into gold, of virtual realms where avatars dance while flesh-and-blood laborers prop up the machine. But let us not mistake the map for the territory.

Valuations soar like kites untethered from earth, their strings cut by winds of speculative fervor. The Nasdaq Composite and the S&P 500, those twin towers of market triumph, have scaled heights that would make even the most ardent optimist pause. Is it still wise to entrust one’s capital to an exchange-traded fund (ETF) tracking the Nasdaq-100, or has this ascent become a perilous climb, demanding a retreat into safer havens?

In the second quarter, Altria’s adjusted EPS growth and revised guidance might make one believe in miracles. Revenue net of excise taxes fell 1.7% to $5.29 billion, while EPS climbed 8.3% to $1.44. One might call this progress, but let’s not confuse a sleight of hand for a standing ovation. The elephant in the room—declining shipment volumes—remains unacknowledged, like a bureaucratic memo buried in a drawer.